20441T

22/23

1．乳房手術後放射線療法4621） Park H, Choi DH, Noh JM, Huh SJ, Park W, Nam SJ, et al. Acute skin toxicity in Korean breast cancer patients carrying BRCA mutations. Int J Radiat Biol. 2014；90（1）：90—4.［PMID：23957571］2） Huszno J, Budryk M, Kołosza Z, Nowara E. The influence of BRCA1／BRCA2 mutations on toxicity related to chemotherapy and radiotherapy in early breast cancer patients. Oncology. 2013；85（5）：278—82.［PMID：24217135］3） Shanley S, McReynolds K, Ardern—Jones A, Ahern R, Fernando I, Yarnold J, et al. Late toxicity is not increased in BRCA1／BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. Clin Cancer Res. 2006；12（23）：7025—32.［PMID：17145824］4） Pierce LJ, Strawderman M, Narod SA, Oliviotto I, Eisen A, Dawson L, et al. Effect of radiotherapy after breast—conserving treatment in women with breast cancer and germline BRCA1／2 mutations. J Clin Oncol. 2000；18（19）：3360—9.［PMID：11013276］5） Pierce LJ, Phillips KA, Griffith KA, Buys S, Gaffney DK, Moran MS, et al. Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer：comparison of breast conservation and mastectomy. Breast Can-cer Res Treat. 2010；121（2）：389—98.［PMID：20411323］6） Drooger J, Akdeniz D, Pignol JP, Koppert LB, McCool D, Seynaeve CM, et al. Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age. Breast Cancer Res Treat. 2015；154（1）：171—80.［PMID：26467044］7） Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD Jr, Stovall M, et al；WECARE Study Collaborative Group. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers：a WEC-ARE study report. Eur J Cancer. 2013；49（14）：2979—85.［PMID：23706288］8） Schlosser S, Rabinovitch R, Shatz Z, Galper S, Shahadi—Dromi I, Finkel S, et al. Radiation—associated secondary malignancies in BRCA mutation carriers treated for breast cancer. Int J Radiat Oncol Biol Phys. 2020；107（2）：353—9.［PMID：32084523］9） Tung NM, Boughey JC, Pierce LJ, Robson ME, Bedrosian I, Dietz JR, et al. Management of hereditary breast cancer：American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgi-cal Oncology guideline. J Clin Oncol. 2020；38（18）：2080—106.［PMID：32243226］参考文献